As of 2026-10-09, the Relative Valuation of bluebird bio Inc (BLUE) is (515.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.97 USD, the upside of bluebird bio Inc based on Relative Valuation is -10478.0%.
The range of the Relative Valuation is (425.29) - (561.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.8x - 27.5x | 25.2x |
| Forward P/E multiples | 19.0x - 27.9x | 25.3x |
| Fair Price | (425.29) - (561.34) | (515.79) |
| Upside | -8657.2% - -11394.5% | -10478.0% |
| Date | P/E |